PA8645501A1 - Un procedimiento para fabricar compuestos enantiomericos del imidazol - Google Patents

Un procedimiento para fabricar compuestos enantiomericos del imidazol

Info

Publication number
PA8645501A1
PA8645501A1 PA20058645501A PA8645501A PA8645501A1 PA 8645501 A1 PA8645501 A1 PA 8645501A1 PA 20058645501 A PA20058645501 A PA 20058645501A PA 8645501 A PA8645501 A PA 8645501A PA 8645501 A1 PA8645501 A1 PA 8645501A1
Authority
PA
Panama
Prior art keywords
imidazol
procedure
manufacture
enantiomeric compounds
enantiomeric
Prior art date
Application number
PA20058645501A
Other languages
English (en)
Spanish (es)
Inventor
Ines Petschen
Juan Sallares
Xavier Camps
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35614444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8645501(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of PA8645501A1 publication Critical patent/PA8645501A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PA20058645501A 2004-09-13 2005-09-12 Un procedimiento para fabricar compuestos enantiomericos del imidazol PA8645501A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200402184A ES2249992B1 (es) 2004-09-13 2004-09-13 Un procedimiento para fabricar compuestos enantiomericos del imidazol.

Publications (1)

Publication Number Publication Date
PA8645501A1 true PA8645501A1 (es) 2006-05-16

Family

ID=35614444

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20058645501A PA8645501A1 (es) 2004-09-13 2005-09-12 Un procedimiento para fabricar compuestos enantiomericos del imidazol

Country Status (23)

Country Link
US (1) US7626038B2 (cg-RX-API-DMAC7.html)
EP (1) EP1794152B1 (cg-RX-API-DMAC7.html)
JP (1) JP5048500B2 (cg-RX-API-DMAC7.html)
KR (1) KR100903922B1 (cg-RX-API-DMAC7.html)
CN (1) CN101023077B (cg-RX-API-DMAC7.html)
AR (1) AR050931A1 (cg-RX-API-DMAC7.html)
AT (1) ATE402171T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005284330B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0515259A (cg-RX-API-DMAC7.html)
CA (1) CA2577247C (cg-RX-API-DMAC7.html)
DE (1) DE602005008454D1 (cg-RX-API-DMAC7.html)
DK (1) DK1794152T3 (cg-RX-API-DMAC7.html)
ES (1) ES2249992B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007002939A (cg-RX-API-DMAC7.html)
NO (1) NO20071817L (cg-RX-API-DMAC7.html)
PA (1) PA8645501A1 (cg-RX-API-DMAC7.html)
PE (1) PE20060720A1 (cg-RX-API-DMAC7.html)
PL (1) PL1794152T3 (cg-RX-API-DMAC7.html)
PT (1) PT1794152E (cg-RX-API-DMAC7.html)
RU (1) RU2413728C2 (cg-RX-API-DMAC7.html)
TW (1) TWI405760B (cg-RX-API-DMAC7.html)
UY (1) UY29115A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006029811A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8635593B2 (en) * 2008-05-13 2014-01-21 Hewlett-Packard Development Company, L.P. Dynamic autocompletion tool
CN112595803A (zh) * 2020-12-31 2021-04-02 海南海神同洲制药有限公司 一种硝酸舍他康唑乳膏的鉴别方法
CN113501814A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑的纯化方法
CN113480517B (zh) * 2021-07-30 2022-09-09 海南海神同洲制药有限公司 3-溴甲基-7-氯苯并[b]噻吩的合成方法
CN113501815A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑晶型的制备方法
CN113816947A (zh) * 2021-08-25 2021-12-21 海南海神同洲制药有限公司 一种硝酸舍他康唑的重结晶方法
CN113735843B (zh) * 2021-09-07 2023-05-26 海南海神同洲制药有限公司 一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1096361B (it) 1978-05-18 1985-08-26 Recordati Chem Pharm Dibenzileteri sostituiti terapeuticamente attivi
JPS57169466A (en) 1981-04-14 1982-10-19 Ota Seiyaku Kk Preparation of imidazole derivative
ES8504779A1 (es) * 1984-02-02 1985-05-01 Ferrer Int Procedimiento de obtencion de nuevos derivados de 1h-imidazol
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
CA1250586A (en) 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
JP3250809B2 (ja) * 1995-01-04 2002-01-28 フエルレル インターナショナル,ソシエダッド アノニマ 1−[2,4−ジクロロ−β−[(7−クロロベンゾ[b]チエニ−3−イル)メトキシ]フェネチル]イミダゾール・1硝酸塩の同質異像B及びC
CZ20012338A3 (cs) * 1998-12-24 2001-12-12 Fujisawa Pharmaceutical Co., Ltd. Imidazolové sloučeniny
CN1191250C (zh) * 2001-09-26 2005-03-02 河北省药物研究所 一种硝酸舍他康唑的合成方法
ES2203316B1 (es) * 2002-02-11 2005-03-01 Ferrer Internacional, S.A. R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.

Also Published As

Publication number Publication date
TW200621756A (en) 2006-07-01
PL1794152T3 (pl) 2008-12-31
US20080108682A1 (en) 2008-05-08
KR20070042206A (ko) 2007-04-20
RU2007113921A (ru) 2008-10-20
UY29115A1 (es) 2005-11-30
JP5048500B2 (ja) 2012-10-17
TWI405760B (zh) 2013-08-21
KR100903922B1 (ko) 2009-06-19
PT1794152E (pt) 2008-10-24
ATE402171T1 (de) 2008-08-15
AR050931A1 (es) 2006-12-06
ES2249992B1 (es) 2007-03-01
US7626038B2 (en) 2009-12-01
WO2006029811A1 (en) 2006-03-23
DK1794152T3 (da) 2008-11-17
RU2413728C2 (ru) 2011-03-10
EP1794152A1 (en) 2007-06-13
MX2007002939A (es) 2007-04-27
CA2577247A1 (en) 2006-03-23
NO20071817L (no) 2007-05-16
EP1794152B1 (en) 2008-07-23
BRPI0515259A (pt) 2008-07-15
HK1105416A1 (en) 2008-02-15
JP2008512421A (ja) 2008-04-24
CA2577247C (en) 2011-07-05
DE602005008454D1 (de) 2008-09-04
CN101023077A (zh) 2007-08-22
PE20060720A1 (es) 2006-07-11
AU2005284330A1 (en) 2006-03-23
CN101023077B (zh) 2012-05-23
AU2005284330B2 (en) 2011-01-06
ES2249992A1 (es) 2006-04-01

Similar Documents

Publication Publication Date Title
CL2008001250S1 (es) Suela para calzado.
CL2008001251S1 (es) Suela para calzado.
CL2008001249S1 (es) Suela para calzado.
CL2008001247S1 (es) Suela para calzado.
CL2008001246S1 (es) Suela para calzado.
CL2008001245S1 (es) Suela para calzado.
ES2648904T3 (es) Suela
GT200500175A (es) Inhibidores de cetp
CY1111793T1 (el) Μυκητοκτονες συνθεσεις
CL2008001242S1 (es) Suela para calzado.
CL2007003295S1 (es) Suela para calzado.
CL2007003298S1 (es) Suela para calzado.
CL2007003296S1 (es) Suela para calzado.
CL2007003297S1 (es) Suela para calzado.
CL2008001248S1 (es) Suela para calzado.
HN2009001165A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
CR11620A (es) Derivados de Imadazo-[1,2,b]-Piridazina para el Tratamiento de Enfermedad Mediada por Cinosa de Tirosina C-Met
DOP2010000148A (es) Derivados bis-(sulfonilzmino) en terapia 066
CL2007003294S1 (es) Suela para calzado.
CU20120071A7 (es) DERIVADOS DE N1-PIRAZOLOESPIROCETONA ÚTILES COMO INHIBIDORES DE ACETIL-CoA CARBOXILASA
CL2008001241S1 (es) Suela para calzado.
CL2008001244S1 (es) Suela para calzado.
NI200800334S (es) Un dispositivo para la aplicación de betún líquido para zapatos.
GT200900259A (es) Nuevos métodos.-
DOP2005000025A (es) Compuestos de heteroaril- y fenilsulfamoilo sustituidos